Platelet-to-lymphocyte ratio (PLR) as a predictor of Covid-19 pneumonia progression

D. Koval (Dnipropetrovsk, Ukraine), L. Konopkina (Dnipropetrovsk, Ukraine), K. Bielosludtseva (Dnipropetrovsk, Ukraine), M. Krykhtina (Dnipropetrovsk, Ukraine)

Source: Virtual Congress 2021 – COVID - 19 biomarkers
Session: COVID - 19 biomarkers
Session type: E-poster
Number: 653

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Koval (Dnipropetrovsk, Ukraine), L. Konopkina (Dnipropetrovsk, Ukraine), K. Bielosludtseva (Dnipropetrovsk, Ukraine), M. Krykhtina (Dnipropetrovsk, Ukraine). Platelet-to-lymphocyte ratio (PLR) as a predictor of Covid-19 pneumonia progression. 653

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lymphocyte-to-monocyte ratio (LMR) as a predictor of Covid-19 pneumonia progression
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Lymphocyte-to-Monocyte ratio (LMR) and Platelet-to-lymphocyte (PLR) ratio levels as a predictors of lung failure in severe Covid-19 pneumonia patients (pts)
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Prognostic value of haematological markers such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in small cell lung cancer.
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Neutrophil CD64 versus Neutrophil/Lymphocyte ratio (NLR) as markers predicting in-hospital outcome in acute exacerbation of COPD
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

The best predictor of COVID-19 pneumonia progression during lung ultrasound (LUS)
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Fibrinogen like the predictor of COVID-19 pneumonia progression
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


The prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with non-small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia.
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018

The composite physiological index strongly predicts mortality in interstitial lung disease (ILD) associated pulmonary hypertension (PH-ILD)
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017

Diagnostic value of CD4/CD8 ratio in induced sputum (IS) in interstitial lung disease (ILD)
Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases
Year: 2004


The role of serum inflammatory markers in the detection of ventilation associated pneumonia (VAP)
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021


Is the BODE index a useful indicator of the outcome in pulmonary rehabilitation (PR) in subjects with chronic respiratory failure (CRF)?
Source: Eur Respir J 2005; 26: Suppl. 49, 721s
Year: 2005

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
Source: Eur Respir J 2008; 31: 349-355
Year: 2008



I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

The best coagulation marker for prediction of COVID-19 pneumonia progression.
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Copeptin as a predictor of survival in ventilator associated pneumonia
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009

COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012

Predictive value of unassisted respiratory rate-tidal volume ratio (RVR) in weaning outcome
Source: Eur Respir J 2001; 18: Suppl. 33, 239s
Year: 2001

Serum procalcitonin (PCT) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007